Acarbose

Active ingredient description

Acarbose is an alpha-glucosidase inhibitors, used in the treatment of diabetes. Inhibitors of a-glucosidase retard the breakdown of carbohydrates in the food and reduce the increase in blood glucose levels, which occurs after each meal.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
A10BF01
Acarbose
A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BF Alpha glucosidase inhibitors
Discover more medicines within A10BF01

Medicines

Acarbose is the active ingredient of these drugs:

Drug
Countries
ACARLYSE

Tunisia

ACAROSE

Hong Kong

AGLUCOSE

Brazil

ALPHA-GLUCOFF

Tunisia

CARBOLESS

Tunisia

CARLIPIN

Hong Kong

DIABICOR

Tunisia

GARBOSE

Singapore

GLUCOBAY

Australia Austria Brazil Canada Hong Kong

GLUCOR

France Tunisia

GLUFIX

Tunisia

GLYBOSAY

Australia

GLYCARBOSE

Tunisia

PRECOSE

United States

TAGLU

Hong Kong

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
GLUCOBAY 100mg Tablets
Summary of product characteristics (SPC)
UK
GLUCOBAY 50mg Tablet
Summary of product characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

T58MSI464G - ACARBOSE

CAS registry number

56180-94-0 - acarbose

SNOMED-CT

386965004 - Acarbose (substance)

Next: Usage